Patrick B. Bolton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patrick B. Bolton has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ali H. Turkmani
Neurosurgery, Mayo Clinic
1 shared publication - Andrew W. Murray
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ
1 shared publication Antoun H. Koht
1 shared publication- Bernard R. Bendok
Department of Neurological Surgery, Mayo Clinic, Phoenix, Arizona, USA
1 shared publication - Bradford B. Smith
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ
1 shared publication - Byeong Yeob Choi
Department of Population Health Sciences University of Texas Health San Antonio San Antonio Texas USA
1 shared publication
Latest Publications
- 15 November 2022
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 44 (16) , 1-7
Adenosine-Assisted Clipping of Intracranial Aneurysms
- 15 November 2022
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 44 (16) , 1-7
Adenosine-Assisted Clipping of Intracranial Aneurysms
- 23 September 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 51 (6) , 607-611
Surgical site infections during the COVID-19 era: A retrospective, multicenter analysis
- 23 September 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 51 (6) , 607-611
Surgical site infections during the COVID-19 era: A retrospective, multicenter analysis
- 12 April 2021
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 131 (1) , 59-70
Survey of Anesthesiologists on Topical Vasoconstrictors and Intravenous Tranexamic Acid for Endoscopic Sinus Surgery
Objectives: Topical vasoconstrictors and intravenous tranexamic acid (IV TXA) are safe and efficacious to decrease bleeding and improve the surgical field during endoscopic sinus surgery (ESS). The purpose of this study was to investigate practice patterns, awareness of clinical evidence, and comfort levels among anesthesia providers regarding these hemostatic agents for ESS. Methods: A total of 767 attending anesthesiologists, residents, and certified registered nurse anesthetists (CRNAs) at 5 United States academic centers were invited to participate in a survey regarding their experience with IV TXA and 3 topical vasoconstrictor medications (oxymetazoline, epinephrine, and cocaine) during ESS. Results: 330 (47%) anesthesia providers responded to the electronic survey. 113 (97%) residents, 92 (83%) CRNAs, and 52 (68%) attendings managed 5 or fewer ESS cases per month. Two-thirds of providers had not reviewed efficacy or safety literature for these hemostatic agents. Oxymetazoline was perceived safest, followed by epinephrine, IV TXA, and cocaine. Respondents considered potential side effects over surgical field visibility when selecting agents. The majority of providers had no formal training on these agents for ESS, but indicated interest in educational opportunities. Conclusion: Many anesthesia providers are unfamiliar with safety and efficacy literature regarding agents used to improve hemostasis for ESS, highlighting a need for development of relevant educational resources. Rhinologic surgeons have an opportunity to communicate with anesthesia colleagues on the use of hemostatic agents to improve the surgical field during ESS.
- 12 April 2021
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 131 (1) , 59-70
Survey of Anesthesiologists on Topical Vasoconstrictors and Intravenous Tranexamic Acid for Endoscopic Sinus Surgery
Objectives: Topical vasoconstrictors and intravenous tranexamic acid (IV TXA) are safe and efficacious to decrease bleeding and improve the surgical field during endoscopic sinus surgery (ESS). The purpose of this study was to investigate practice patterns, awareness of clinical evidence, and comfort levels among anesthesia providers regarding these hemostatic agents for ESS. Methods: A total of 767 attending anesthesiologists, residents, and certified registered nurse anesthetists (CRNAs) at 5 United States academic centers were invited to participate in a survey regarding their experience with IV TXA and 3 topical vasoconstrictor medications (oxymetazoline, epinephrine, and cocaine) during ESS. Results: 330 (47%) anesthesia providers responded to the electronic survey. 113 (97%) residents, 92 (83%) CRNAs, and 52 (68%) attendings managed 5 or fewer ESS cases per month. Two-thirds of providers had not reviewed efficacy or safety literature for these hemostatic agents. Oxymetazoline was perceived safest, followed by epinephrine, IV TXA, and cocaine. Respondents considered potential side effects over surgical field visibility when selecting agents. The majority of providers had no formal training on these agents for ESS, but indicated interest in educational opportunities. Conclusion: Many anesthesia providers are unfamiliar with safety and efficacy literature regarding agents used to improve hemostasis for ESS, highlighting a need for development of relevant educational resources. Rhinologic surgeons have an opportunity to communicate with anesthesia colleagues on the use of hemostatic agents to improve the surgical field during ESS.